After a few months of intermittent fasting, people with metabolic syndrome see a small drop in their LDL (bad) cholesterol, which is good for heart health.
Scientific Claim
Intermittent fasting reduces LDL cholesterol by 0.22 mmol/L in adults with metabolic syndrome over interventions averaging 3 months, indicating a modest reduction in 'bad' cholesterol.
Original Statement
“low-density lipoprotein level by 0.22 mmol/L (95% CIs: −0.37; −0.07)”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The effect is statistically significant and derived from RCTs. The language appropriately reflects the magnitude and direction of the effect.
Evidence from Studies
Supporting (1)
Unknown Title
This study found that people with metabolic syndrome who tried intermittent fasting lowered their 'bad' cholesterol by exactly 0.22 mmol/L, just like the claim says — so the claim is backed up by solid evidence.